Digipharm Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Digipharm General Information

Description

Developer of a medical procurement and patient engagement platform designed to accelerate the transformation to value-based healthcare. The company facilitates outcome-based healthcare contracting using blockchain, artificial intelligence, reimbursement of healthcare, and associated technologies that eliminate administrative burdens, enabling healthcare professionals to improve patient outcomes and reduce costs for health systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 152-160 City Road
  • Kemp House
  • London EC1V 2NX
  • England, United Kingdom
Primary Industry
Practice Management (Healthcare)
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 152-160 City Road
  • Kemp House
  • London EC1V 2NX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 13-Jan-2022 Completed Generating Revenue
2. Accelerator/Incubator 07-Oct-2021 Completed Generating Revenue
1. Accelerator/Incubator 02-Jun-2020 Completed Generating Revenue
To view Digipharm’s complete valuation and funding history, request access »

Digipharm Patents

Digipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3861559-A1 Computer system and method for determining efficacy of a medical treatment for a medical condition Active 01-Oct-2018
EP-3861559-B1 Computer system and method for determining efficacy of a medical treatment for a medical condition Active 01-Oct-2018
EP-3861559-C0 Computer system and method for determining efficacy of a medical treatment for a medical condition Active 01-Oct-2018
US-12020825-B2 Computer system and method for determining efficacy of a medical treatment for a medical condition Active 01-Oct-2018
US-20210398687-A1 Computer system and method for determining efficacy of a medical treatment for a medical condition Active 01-Oct-2018 G16H50/70
To view Digipharm’s complete patent history, request access »

Digipharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Digipharm Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gawah Holdings PE/Buyout Minority
DMS Accelerator Accelerator/Incubator Minority
To view Digipharm’s complete investors history, request access »

Digipharm FAQs

  • When was Digipharm founded?

    Digipharm was founded in 2017.

  • Where is Digipharm headquartered?

    Digipharm is headquartered in London, United Kingdom.

  • What is the size of Digipharm?

    Digipharm has 14 total employees.

  • What industry is Digipharm in?

    Digipharm’s primary industry is Practice Management (Healthcare).

  • Is Digipharm a private or public company?

    Digipharm is a Private company.

  • What is Digipharm’s current revenue?

    The current revenue for Digipharm is .

  • Who are Digipharm’s investors?

    Gawah Holdings and DMS Accelerator have invested in Digipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process